Suloexide in the Treatment of Early Stages of COVID-19

NCT04483830 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

243

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: Sulodexide
DRUG: Placebo

Sponsor

Clinedem

Collaborators

[object Object]